idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
23.04.2025 09:47

Better insights into the hepatitis D virus

Dr. Jan Grabowski Presse- und Öffentlichkeitsarbeit
TWINCORE - Zentrum für Experimentelle und Klinische Infektionsforschung

    Hannover researchers develop stem cell-based infection model

    Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people worldwide are infected with HDV. Currently, there are only a few treatment options. A team of researchers from TWINCORE, the Centre for Experimental and Clinical Infection Research in Hannover, has developed a stem cell-based infection model for HDV and has used it to discover a possible target for an attack on the virus. They are now publishing their results in the scientific journal JHEP Reports.

    Hepatitis D virus is a so-called satellite virus. Its genetic blueprint contains only a single protein, and it uses components of the hepatitis B virus (HBV) as a shell. It therefore depends on the presence of HBV, and the hepatitis B vaccination also protects against HDV. Nevertheless, HDV is responsible for the most severe form of viral hepatitis. In addition to the previous therapy with interferon-alpha, Hepcludex has recently become available as a drug that can effectively prevent HDV from entering liver cells. However, Hepcludex has no direct antiviral effect and cannot prevent the daughter cells from also carrying the virus when infected liver cells divide. Researchers are therefore looking for new antiviral agents for combination therapy.

    Dr Arnaud Carpentier, a postdoctoral researcher at the Institute of Experimental Virology at TWINCORE, is an expert in stem cell-based infection models and has now developed one for the study of HDV infections. ‘Our stem cell-based cell culture system is a valuable model to study viral infections,’ says Carpentier. ‘The cells are almost identical to primary liver cells and therefore offer more realistic conditions than the liver cell lines previously used in hepatitis research.’

    To gain a more precise insight into the processes that occur during HDV infection, Carpentier and his team have examined gene activity in the infected cells in more detail. To do this, they used a technique known as single-cell sequencing. ‘On the basis of the sequencing, we can divide the HDV infected cells into two groups,’ says Carpentier. ‘In some of the infected cells, the virus replicates actively, while in the other half it is unable to reproduce.’ The sequencing results showed a crucial difference between the two cell populations: the expression of the gene IRF1.

    IRF1 stands for Interferon Regulatory Factor 1. ‘IRF1 is a transcription factor that plays a role in cellular immune defence,’ says Frauke Lange, a doctoral student in Carpentier’s team, and first author of the article. ‘In this work, we show that IRF1 overexpression inhibits HDV infection. IRF1 also prevents the spread of the virus during cell division, a step not targeted by Hepcludex.”

    IRF1 regulates 101 downstream genes. Lange now hopes to identify the downstream genes that exert the observed antiviral effect against HDV. ‘That's why we want to take a closer look at the genes regulated by IRF1 in the future’, she says. The current results pave the way for the development ofnew treatment of HDV infection to be used in association with Hepcludex.

    The work was supported by the RESIST Cluster of Excellence and by funds from the German Research Foundation (DFG), which were acquired by Prof. Thomas Pietschmann, head of the Institute for Experimental Virology.


    Wissenschaftliche Ansprechpartner:

    Dr. Arnaud Carpentier arnaud.carpentier@twincore.de


    Originalpublikation:

    https://doi.org/10.1016/j.jhepr.2025.101429


    Weitere Informationen:

    https://twincore.de/news/better-insights-into-the-hepatitis-d-virus This press release on twincore.de


    Bilder

    Dr. Arnaud Carpentier and Frauke Lange in the lab
    Dr. Arnaud Carpentier and Frauke Lange in the lab

    ©TWINCORE/Grabowski


    Merkmale dieser Pressemitteilung:
    Journalisten, Wissenschaftler, jedermann
    Biologie, Medizin
    überregional
    Wissenschaftliche Publikationen
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).